FDA Heads to Court to Defend Unprecedented Decision Protecting Lung Drug Monopoly From Liquidia Competition
Based on Hunterbrook Media’s reporting, Hunterbrook Capital is long Liquidia (NASDAQ: $LQDA)at the time of publication. Positions may change at any time. See full disclosures below. Drug development is tightly regulated, designed to strike a balance …